Jul 27, 2026 07:01AM
Jul 9, 2026 05:01PM
Jun 30, 2026 07:31AM
Jun 29, 2026 03:27PM
Jun 29, 2026 06:13AM
Jun 17, 2026 10:15AM
Jun 1, 2026 07:31AM Biohaven begins first human trial of brain-penetrant drug BHV-8100
May 27, 2026 10:16AM
May 27, 2026 07:31AM
May 26, 2026 07:31AM
May 12, 2026 06:52AM
May 4, 2026 05:11PM
May 4, 2026 04:26PM
Apr 13, 2026 05:18AM Canaccord Starts Biohaven Pharma (BHVN) at Buy
Apr 2, 2026 05:09AM
Mar 16, 2026 05:28PM
Mar 9, 2026 01:55PM
Mar 4, 2026 06:45AM
Mar 3, 2026 02:43PM
Mar 3, 2026 09:01AM
Mar 3, 2026 08:43AM Piper Sandler: 'Biohaven Pharma (BHVN) Gearing Up for a Catalyst-Rich 2026'
Mar 2, 2026 08:18PM
Feb 23, 2026 08:43AM
Feb 5, 2026 04:21PM
Jan 21, 2026 05:04AM
Jan 12, 2026 01:44PM
Jan 12, 2026 11:20AM
Dec 26, 2025 08:18AM Stifel Reiterates Xenon Pharmaceuticals (XENE) at Buy following Biohaven's failure
Dec 26, 2025 06:40AM
Dec 26, 2025 06:08AM
Dec 11, 2025 07:02AM
Dec 3, 2025 06:07AM
Nov 26, 2025 04:18AM
Nov 17, 2025 07:38AM
Nov 12, 2025 08:35AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $14 at Citi
Nov 11, 2025 04:29AM
Nov 10, 2025 07:40AM
Nov 6, 2025 08:37AM
Nov 6, 2025 02:23AM
Nov 5, 2025 04:09PM
Nov 5, 2025 03:33PM
Nov 5, 2025 10:51AM Raymond James Comments on Biohaven (BHVN) Post Management Call
Nov 5, 2025 10:00AM
Nov 5, 2025 08:20AM
Nov 5, 2025 08:19AM
Nov 5, 2025 08:17AM
Nov 5, 2025 08:16AM
Nov 5, 2025 06:10AM
Nov 5, 2025 01:56AM FDA rejects Biohaven drug application for rare brain disorder
Nov 3, 2025 10:00AM

443,898 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All